Qube Research & Technologies (QRT)’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-502,464
Closed -$11.4M 3527
2025
Q2
$11.4M Buy
+502,464
New +$11.9M 0.01% 1213
2024
Q2
Sell
-30,746
Closed -$2.44M 3724
2024
Q1
$2.44M Buy
30,746
+24,942
+430% +$2.04M ﹤0.01% 1642
2023
Q4
$451K Buy
5,804
+590
+11% +$43.7K ﹤0.01% 2356
2023
Q3
$367K Sell
5,214
-5,349
-51% -$400K ﹤0.01% 2161
2023
Q2
$841K Sell
10,563
-118,342
-92% -$8.55M ﹤0.01% 1369
2023
Q1
$9.31M Buy
128,905
+42,732
+50% +$3.33M 0.04% 494
2022
Q4
$7.09M Buy
+86,173
New +$7.1M 0.04% 576
2021
Q3
Sell
-15,751
Closed -$988K 2130
2021
Q2
$988K Buy
+15,751
New +$988K 0.01% 938
2020
Q3
Sell
-23,099
Closed -$580K 1616
2020
Q2
$580K Buy
+23,099
New +$577K 0.01% 1051
2018
Q4
Sell
-2,892
Closed -$102K 292
2018
Q3
$102K Buy
2,892
+1,890
+189% +$75.3K 0.01% 749
2018
Q2
$41K Buy
+1,002
New +$40.4K 0.03% 577

Other funds holding ACHC

Qube Research & Technologies (QRT)'s ACHC Position: Q3 2025 in Review

Qube Research & Technologies (QRT) sold out of Acadia Healthcare (ACHC) in Q3 2025, closing a stake of 502,464 shares — an estimated $11.4M sold.

Qube Research & Technologies (QRT) first reported a position in ACHC in Q2 2018 and held it in 11 quarters. The position peaked at $11.4M in Q2 2025. 270 funds tracked by Wall St. Rank hold ACHC as of Q3 2025.

  • Qube Research & Technologies (QRT) reported no remaining Acadia Healthcare position as of Q3 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 502,464 Acadia Healthcare shares in Q3 2025, an estimated $11.4M.
  • Qube Research & Technologies (QRT) first reported a position in Acadia Healthcare in Q2 2018 and held it in 11 quarters.
  • Qube Research & Technologies (QRT)'s Acadia Healthcare position peaked at $11.4M in Q2 2025.
  • 270 funds tracked by Wall St. Rank held Acadia Healthcare as of Q3 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2025, filed 14 Nov 2025.